early detection
CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood TestÂ
CorePath will develop and offer UK-based Cizzle's test in the US, with royalty agreements on all product and services offerings related to the test.Â
Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE
Dante labs will market the test in Italy and the UAE, with Mainz initially processing samples in its lab and Dante later adopting IVD kits for in-house use.
Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology
The partners' first project is an expansion of Delfi's previously announced prospective study of its blood-based screening assay in patients with a high risk of lung cancer.
Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program
Premium
The test is first available to employees over age 50 covered under Intermountain's SelectHealth, but the health system has a bigger five-year plan.
Having officially launched its Shield colorectal cancer screening assay as an LDT, Guardant stands to benefit from a head start in clinical establishment.